Cite

HARVARD Citation

    Ebos, J. et al. (n.d.). Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy. EMBO molecular medicine. 6 (12), pp. 1561-1576. [Online]. 
  
Back to record